Article 29 May 2026 pH, Prosecution History Estoppel, And Patent Scope: Three Lessons From The Federal Circuit's Latest Hatch-Waxman Ruling United States IP
Article 12 May 2026 Are Skinny Labels Getting Heavier For Generics? Key Takeaways From Hikma v. Amarin, The Supreme Court's First Patent Case Since 2023 United States IP
Article 06 Jan 2025 Only Drugs Allowed: Federal Circuit Affirms Order To Delist Device Patents From The Orange Book United States Healthcare
Article 01 Jul 2024 The FTC Strikes Out: Drug Manufacturers Refuse To Play Ball And Delist Orange Book Patents In Response To FTC Warning Letters United States IP
Article 30 Apr 2024 Red Alert On The Orange Book: The FTC Continues To Crack Down On Improperly Listed Drug Patents United States IP
Article 19 Jan 2024 Throwing The (Orange) Book At Pharmaceutical Manufacturers: FTC Challenges Over 100 Drug Product Patents Listed In FDA Publication United States Healthcare